Log in to search using one of your social media accounts:


Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes

ConclusionMore than 60% of women undergoing RRS were BRCAm negative or untested. Counselling of high-risk women without defined germline mutations remains a challenge for gynaecologists because the likelihood of removing STIC lesions or occult invasive cancer is low. Removal of coincidental pathology may give added value to RRS in these women.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research

Related Links:

More News: Biomedical Science | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Endometrial Cancer | Endometriosis | Fallopian Tube Cancer | General Medicine | Genetics | Hysterectomy | Ireland Health | OBGYN | Ovarian Cancer | Ovaries | Pathology | Science | Serous Carcinoma | Teaching | Teaching Hospitals | Universities & Medical Training | Women